MedCaps IS
En vente sur le marché américain (selon le DSLD)
XYMOGEN, food supplement from the US market
MedCaps IS (XYMOGEN), a food supplement au code-barres 871149000417, is described by its US market label, recorded on 18 July 2023. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. Doses of niacine are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label, entered on 18 July 2023. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 1,000 µg a day according to the label (at most 1 serving a day), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- XYMOGEN
- Barcode
- 871149000417
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Hypromellose, Water, Stearic Acid, Magnesium Stearate, Silica
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Thiamine | Vitamin | 100 mg |
| Niacin | Vitamin | 100 mg |
| Biotin | Vitamin | 10,000 µg |
| Chromium | Mineral | 1,000 µg |
| Fenugreek seed extract (Trigonella foenum-graecum) | Plant | 300 mg |
| Bitter Gourd Fruit Extract (Momordica charantia) | Plant | 150 mg |
| Gymnema leaf extract (Gymnema sylvestre) | Plant | 100 mg |
| Vanadium | Mineral | 5 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: MedCaps IS
Entered into DSLD on 26 December 2020. Retirée du marché américain le 18 August 2022 (selon le DSLD).- Same quantity, different name: Bitter Gourd extract in this version; Bitter Gourd Fruit Extract on the displayed label (150 mg)
- Same quantity, different name: Fenugreek extract in this version; Fenugreek seed extract on the displayed label (300 mg)
- Same quantity, different name: Gymnema extract in this version; Gymnema leaf extract on the displayed label (100 mg)
Official label: MedCaps IS
Entered into DSLD on 25 August 2015. Retirée du marché américain le 28 February 2019 (selon le DSLD).- Same quantity, different name: Bitter Gourd extract in this version; Bitter Gourd Fruit Extract on the displayed label (150 mg)
- Same quantity, different name: Fenugreek extract in this version; Fenugreek seed extract on the displayed label (300 mg)
- Same quantity, different name: Gymnema extract in this version; Gymnema leaf extract on the displayed label (100 mg)
Official label: MedCaps IS
Entered into DSLD on 25 November 2013. Retirée du marché américain le 6 August 2015 (selon le DSLD).- Same quantity, different name: Bitter Gourd Extract in this version; Bitter Gourd Fruit Extract on the displayed label (150 mg)
- Same quantity, different name: Fenugreek extract in this version; Fenugreek seed extract on the displayed label (300 mg)
- Same quantity, different name: Gymnema extract in this version; Gymnema leaf extract on the displayed label (100 mg)
Official label: MedCaps IS
Entered into DSLD on 23 March 2012. En vente sur le marché américain (selon le DSLD).- Same quantity, different name: Bitter Gourd Extract in this version; Bitter Gourd Fruit Extract on the displayed label (150 mg)
- Same quantity, different name: Fenugreek Seed Extract 50% in this version; Fenugreek seed extract on the displayed label (300 mg)
- Same quantity, different name: Gymnema Sylvestre Leaf Extract 25% in this version; Gymnema leaf extract on the displayed label (100 mg)
- Different unit, without conversion : Biotin: 10 mg in this version; 10,000 mcg on the displayed label
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : XYMOGEN